EventsIn the BHV portfolio: MATCH Biosystems nanotechnology in El Español D+I

February 18th, 2021by BHV Partners

https://bhvpartners.com/wp-content/uploads/2021/02/Captura-de-pantalla-2021-02-18-134224.png

MATCH Biosystems nanotechnology reaches in vitro diagnosis of infections. The new generation of devices from this Valencian startup offers results in less than an hour, with a sensitivity over 90%.

see article in:

El Español D+I

#biomedical
#investment
#startups
venture builder

In the BHV portfolio: Biel Glasses, ‘smart’ glasses to adapt the environment to people with low vision

BHV Partners and Aimentia cited among the 10 startups with the greatest potential in the Digital Health sector in Spain

Created by Gemma Escarré Comms

We use our own and third party cookies to improve your experience and to optimize the operation on the web. If you continue browsing we consider that you accept our cookies policy. More information

EventsIn the BHV portfolio: MATCH Biosystems nanotechnology in El Español D+I

September 13th, 2023Marta Príncep joins the jury of the 2023 Expansión StartUp Awards

July 3rd, 2023Launch of Bioindustry Association of the Murcia Region presided by Joaquín Gómez Moya

June 29th, 2023BHV Partners opens a round of €2.5 million to accelerate its growth

June 19th, 2023BHV Partners takes part in Elisava Degree Show 2023 as venture builder

April 24th, 2023BHV Partners and Elisava seal a licensing agreement on the first graphene electronic tattoo